Trustees

Zoe set up ZPB Ltd in August 2009 to help private-, public- and third-sector organisations grow reach and influence in the health sector. She directs many of ZPB’s strategic accounts and has led organisations through major crisis situations, helped reposition well-established brands within the health sector and launched several new organisations into the UK market. She specialises in complex stakeholder engagement and management, content and strategic communications.

Prior to ZPB, Zoe was head of marketing and communications at Dr Foster. During her tenure there, the company trebled in size. Zoe regularly speaks on market access, health tech and how to forge successful cross-sector partnerships, and believes passionately in the role of SMEs in stimulating healthcare innovation and the economy. She manages the Cambridge Health Network, is a fellow of the RSA, and a member of The Entrepreneurs’ Organisation (EOUK). Until recently, she was one of the founder members and treasurer of the Emerging Leaders Network.

Zoe is on the strategy development committee for C3’s Board. 

Sally Gilding started her professional career at The Law Commission, an independent body created by statue to keep the application of English law under review. From there, she moved to Clifford Chance, a major international law firm, covering corporate finance and capital markets, before entering the banking industry. Following 18 years at Deutsche Bank, Sally established her own independent business, harnessing her experience and expertise in corporate trust and corporate services.

Sally has held numerous board-level appointments including CEO of a Corporate Trust company and also co-chaired the Women in European Business annual conference. She has been active in corporate social responsibility initiatives supporting Inner London schools. Sally has a law degree from the University of London and a BA in psychology and political science from The Australian National University, Canberra.

Sally is chair of C3’s Board. 

John is Ambassador of Diabetes UK having previously been a trustee and vice chair. He has chair of the iDEAL Group. From 2010-2016 he was vice president of the International Diabetes Federation, chairing and serving on various boards and committees, including World Diabetes Congress, Finance, and External Relations.. In 2015 John founded Changing Health and led the spin out from Newcastle University, the first evidence based education and behaviour change toolkit incorporating digital and telephone based personalised coaching for people with chronic diseases in the UK, Netherlands and Switzerland. Today, he provides strategic advice to a number of health businesses on international growth, financial and commercial development.

John has built a number of consumer-centric businesses in the UK and across Europe at including GSK, Carphone Warehouse as well as private equity-backed turnarounds. John is a fellow of the ICAEW and attended Wharton Business School. He has type 1 diabetes and leads an active lifestyle, including participating in international cycling events.

John is chair of the finance committee for C3’s Board. 

Harpreet Sood is a physician currently working on national health-care policy and strategy focused on digital health as a Associate Chief Clinical Information Officer for the NHS. Prior to this, Harpreet was Senior Fellow in the office of the chief executive officer at NHS England. He worked on co-designing and scaling up the National Diabetes Prevention Programme, and co-developed the Five Year Forward View (2014).  

His passion lies in public health and disease prevention, particularly in how the latest advances in technology, data availability and digital health can improve population and public health on a system level – and he has worked for digital health start-ups, including co-founding Mighty Lungs (a video game to improve children’s adherence of preventative asthma medication). Harpreet holds a Masters in Public Health from Harvard University and has previously been a fellow in administration and health policy at Brigham and Women’s Hospital in Boston. Harpreet sits on the NHS Prevention Board and is Vice Chair for British Computer Society (Health). 

Harpreet is on the finance committee for C3’s Board. 

Caroline has enjoyed a long career in healthcare. She has a clinical background and has worked in both the NHS and the global healthcare private sector, building clinical leadership capability and facilitating organisational and service transformation. In 2020 she joined IBM as an associate partner. She will be working with clinicians across the health care ecosystem to redesign care pathways supported by digital transformation.

Caroline is vice chair of C3 and holds two further board positions. She is a Non Executive Director of one of the largest NHS Provider Trusts in England. She is also a board member of healthcare start up CareRooms.Com.

Professor Tracey Pérez Koehlmoos, PhD, MHA is a health systems and policy scientist who specialises in leading complex tasks, program development and capacity building across the spectrum of health systems building blocks. She currently leads a robust health services and policy research program and the PhD in public health program in support of the US Military Health System at the Uniformed Services University of the Health Sciences. 

Previously she served as the Special Assistant to the Assistant Commandant of the Marine Corps. She has more than 150 publications and multimedia products. Prior to transitioning to domestic and defense healthcare, she lived and worked in Saudi Arabia, Pakistan, Nepal, Bangladesh and Indonesia. She cut her teeth in public health leading the Health & Family Planning Systems Programme at ICDDR,B in Dhaka Bangladesh. There, she scaled up zinc for the treatment of childhood diarrhea; founded the Centre for Control of Chronic Diseases and created and led the Centre for Systematic Review, which focuses on health systems and policy issues in low- and middle-income countries and conducted capacity building in this methodology across South Asia.